Skip to main content
Erschienen in: Esophagus 4/2011

01.12.2011 | Congress Report: President's Lecture

History of the Japanese Classification of Esophageal Cancer

verfasst von: Hiromasa Fujita

Erschienen in: Esophagus | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Excerpt

A brief history of the Japanese Classification of Esophageal Cancer [1] is elucidated here. It is not only the Japanese version of the TNM Classification of Malignant Tumours [2], but also an heirloom of the Japan Esophageal Society (JES). Many definitions and classifications concerning esophageal cancer have been described. The Japanese versions of the first to ninth editions [311] were prepared by the Japanese Society for Esophageal Diseases (JSED), which was the predecessor of the JES. They were named the “Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus.” In 2003, the Japanese Society for Esophageal Diseases (JSED) changed its name to the Japan Esophageal Society. The Japanese version of its 10th edition [12] was published in 2007, and the following year its English version [1] was published under the title of the “Japanese Classification of Esophageal Cancer” in order to distinguish it from the Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus, the first edition of which was published in 2000 [13]. Many guidelines concerning the treatment of esophageal cancer have been described. …
Literatur
1.
Zurück zum Zitat Japan Esophageal Society. Japanese Classification of Esophageal Cancer. 10th English ed. Tokyo: Kanehara; 2008. Japan Esophageal Society. Japanese Classification of Esophageal Cancer. 10th English ed. Tokyo: Kanehara; 2008.
2.
Zurück zum Zitat International Union Against Cancer. TNM Classification of Malignant Tumours, 7th edn. In: Sobin LH, Gospodarowicz MK, Wittekind Ch, editors. New York: Wiley-Blackwell; 2009. International Union Against Cancer. TNM Classification of Malignant Tumours, 7th edn. In: Sobin LH, Gospodarowicz MK, Wittekind Ch, editors. New York: Wiley-Blackwell; 2009.
3.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 1st ed. Tokyo: Japanese Society for Esophageal Diseases; 1969. (in Japanese). Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 1st ed. Tokyo: Japanese Society for Esophageal Diseases; 1969. (in Japanese).
4.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 2nd ed. Tokyo: Kanehara; 1972. (in Japanese). Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 2nd ed. Tokyo: Kanehara; 1972. (in Japanese).
5.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 3rd ed. Tokyo: Kanehara; 1973. (in Japanese). Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 3rd ed. Tokyo: Kanehara; 1973. (in Japanese).
6.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 4th ed. Tokyo: Kanehara; 1974. (in Japanese). Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 4th ed. Tokyo: Kanehara; 1974. (in Japanese).
7.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on carcinoma of the Esophagus. 5th ed. Tokyo: Kanehara; 1976. (in Japanese). Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on carcinoma of the Esophagus. 5th ed. Tokyo: Kanehara; 1976. (in Japanese).
8.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 6th ed. Tokyo: Kanehara; 1984. (in Japanese). Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 6th ed. Tokyo: Kanehara; 1984. (in Japanese).
9.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 7th ed. Tokyo: Kanehara; 1989. (in Japanese). Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 7th ed. Tokyo: Kanehara; 1989. (in Japanese).
10.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 8th ed. Tokyo: Kanehara; 1992. (in Japanese). Japanese Society for Esophageal Diseases. Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 8th ed. Tokyo: Kanehara; 1992. (in Japanese).
11.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 9th ed. Tokyo: Kanehara; 1999. (in Japanese). Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 9th ed. Tokyo: Kanehara; 1999. (in Japanese).
12.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 10th ed. Tokyo: Kanehara; 2007. (in Japanese). Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 10th ed. Tokyo: Kanehara; 2007. (in Japanese).
13.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus. 1st ed. Tokyo: Kanehara; 2002. (in Japanese). Japanese Society for Esophageal Diseases. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus. 1st ed. Tokyo: Kanehara; 2002. (in Japanese).
14.
Zurück zum Zitat 50th Annual Meeting of the Japanese Society for Esophageal Diseases. 30 years’ Progress of the Japanese Society for Esophageal Diseases. In: Yamada A, editor. Tokyo: 50th Annual Meeting of the Japanese Society for Esophageal Diseases; 1998 (in Japanese). 50th Annual Meeting of the Japanese Society for Esophageal Diseases. 30 years’ Progress of the Japanese Society for Esophageal Diseases. In: Yamada A, editor. Tokyo: 50th Annual Meeting of the Japanese Society for Esophageal Diseases; 1998 (in Japanese).
15.
Zurück zum Zitat International Union Against Cancer. TNM Classification of Malignant Tumours, 1st edn. In: Committee on TNM Classification, editor. Geneve: Internal Union Against Cancer; 1968. International Union Against Cancer. TNM Classification of Malignant Tumours, 1st edn. In: Committee on TNM Classification, editor. Geneve: Internal Union Against Cancer; 1968.
16.
Zurück zum Zitat Japanese Research Society for Gastric Cancer. General rules for the gastric cancer study in surgery and pathology. 6th ed. Tokyo: Kanehara; 1968. (in Japanese). Japanese Research Society for Gastric Cancer. General rules for the gastric cancer study in surgery and pathology. 6th ed. Tokyo: Kanehara; 1968. (in Japanese).
17.
Zurück zum Zitat Japanese Research Society for Gastric Cancer. Proposal of General Rules for the Gastric Cancer Study. 1st ed. Tokyo: Japanese Research Society for Gastric Cancer; 1962. (in Japanese). Japanese Research Society for Gastric Cancer. Proposal of General Rules for the Gastric Cancer Study. 1st ed. Tokyo: Japanese Research Society for Gastric Cancer; 1962. (in Japanese).
18.
Zurück zum Zitat Japanese Research Society for Gastric Cancer. General rules for the Gastric Cancer Study in surgery and pathology. 4th ed. Tokyo: Kanehara; 1966. (in Japanese). Japanese Research Society for Gastric Cancer. General rules for the Gastric Cancer Study in surgery and pathology. 4th ed. Tokyo: Kanehara; 1966. (in Japanese).
19.
Zurück zum Zitat Nakayama K, Yanagisawa F, Nabeya K, Tamiya T, Kobayashi S, Makino K. Concentrated preoperative irradiation therapy. Arch Surg. 1963;87:1003–18.CrossRef Nakayama K, Yanagisawa F, Nabeya K, Tamiya T, Kobayashi S, Makino K. Concentrated preoperative irradiation therapy. Arch Surg. 1963;87:1003–18.CrossRef
20.
Zurück zum Zitat Akakura I. With a progress of treatment for esophageal cancer. Jpn J Thorac Cardiovasc Surg. 1969;15:87–92. (in Japanese). Akakura I. With a progress of treatment for esophageal cancer. Jpn J Thorac Cardiovasc Surg. 1969;15:87–92. (in Japanese).
21.
Zurück zum Zitat Nabeya K, Akiyama H, Nakayama R, Ogawa Y, Soga J. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg. 1976;6:69–86.CrossRef Nabeya K, Akiyama H, Nakayama R, Ogawa Y, Soga J. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg. 1976;6:69–86.CrossRef
22.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–16.PubMedCrossRef Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–16.PubMedCrossRef
23.
Zurück zum Zitat Kasai M. Surgical treatment of esophageal cancer–the path to improve the outcomes. J Jpn Surg Soc. 1980;81:845–53. (in Japanese). Kasai M. Surgical treatment of esophageal cancer–the path to improve the outcomes. J Jpn Surg Soc. 1980;81:845–53. (in Japanese).
24.
Zurück zum Zitat Iizuka T, Ide H, Kakegawa T, Sasaki K, Takagi I, Ando N, Mori S, Arimori M, Tsugane S. Preoperative radiotherapy for esophageal carcinoma, randomized evaluation trial in eight institutions. Chest. 1988;93:1054–8.PubMedCrossRef Iizuka T, Ide H, Kakegawa T, Sasaki K, Takagi I, Ando N, Mori S, Arimori M, Tsugane S. Preoperative radiotherapy for esophageal carcinoma, randomized evaluation trial in eight institutions. Chest. 1988;93:1054–8.PubMedCrossRef
25.
Zurück zum Zitat Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest. 1993;104:203–7.CrossRef Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest. 1993;104:203–7.CrossRef
26.
Zurück zum Zitat Kinoshita I, Ohashi I, Nakagawa K, Kajitani T, Kaneda K, Tsuya A. Lymph node metastasis in esophageal cancer; with special reference to upper mediastinum and measures for its treatment. Jpn J Gastroenetrol Surg. 1976;9:424–30. (in Japanese).CrossRef Kinoshita I, Ohashi I, Nakagawa K, Kajitani T, Kaneda K, Tsuya A. Lymph node metastasis in esophageal cancer; with special reference to upper mediastinum and measures for its treatment. Jpn J Gastroenetrol Surg. 1976;9:424–30. (in Japanese).CrossRef
27.
Zurück zum Zitat Sannohe Y, Hiratsuka R, Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg. 1981;141:216–8.PubMedCrossRef Sannohe Y, Hiratsuka R, Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg. 1981;141:216–8.PubMedCrossRef
28.
Zurück zum Zitat Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48:411–20.PubMedCrossRef Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48:411–20.PubMedCrossRef
29.
Zurück zum Zitat International Union Against Cancer. TNM Classification of Malignant Tumours, 6th edn. In: Sobin LH, Wittekind Ch, editors. New York: Wiley-Liss; 2002. International Union Against Cancer. TNM Classification of Malignant Tumours, 6th edn. In: Sobin LH, Wittekind Ch, editors. New York: Wiley-Liss; 2002.
30.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 9th English ed. Tokyo: Kanehara; 2001. Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus. 9th English ed. Tokyo: Kanehara; 2001.
31.
Zurück zum Zitat Japan Esophageal Society. Guidelines for diagnosis and treatment of carcinoma of the esophagus. 2nd ed. Tokyo: Kanehara; 2007. (in Japanese). Japan Esophageal Society. Guidelines for diagnosis and treatment of carcinoma of the esophagus. 2nd ed. Tokyo: Kanehara; 2007. (in Japanese).
32.
Zurück zum Zitat Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, Tamai S, Toh Y, Matsubara H. Guidelines for diagnosis and treatment of carcinoma of the esophagus, April 2007 edition: part I, Edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.CrossRef Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, Tamai S, Toh Y, Matsubara H. Guidelines for diagnosis and treatment of carcinoma of the esophagus, April 2007 edition: part I, Edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.CrossRef
33.
Zurück zum Zitat Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, Tamai S, Toh Y, Matsubara H. Guidelines for diagnosis and treatment of carcinoma of the esophagus, April 2007 edition: part II, Edited by the Japan Esophageal Society. Esophagus. 2008;5:117–32.CrossRef Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, Tamai S, Toh Y, Matsubara H. Guidelines for diagnosis and treatment of carcinoma of the esophagus, April 2007 edition: part II, Edited by the Japan Esophageal Society. Esophagus. 2008;5:117–32.CrossRef
34.
Zurück zum Zitat Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef
35.
Zurück zum Zitat Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part II and III. Esophagus. 2009;6:71–94.CrossRef Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part II and III. Esophagus. 2009;6:71–94.CrossRef
36.
Zurück zum Zitat Sano M, Okuda S, Tamura H. Esophagoscopy using Lugol staining—diagnosis of esophageal cancer (in Japanese). In: Takemoto T, Kawai K, Ida K, Suzuki S, editors. Endoscopic staining for gastrointestinal cancer. Tokyo: Igaku Tosho Shuppan Co. Ltd; 1978. p. 13–24. Sano M, Okuda S, Tamura H. Esophagoscopy using Lugol staining—diagnosis of esophageal cancer (in Japanese). In: Takemoto T, Kawai K, Ida K, Suzuki S, editors. Endoscopic staining for gastrointestinal cancer. Tokyo: Igaku Tosho Shuppan Co. Ltd; 1978. p. 13–24.
37.
Zurück zum Zitat Makuuchi H, Machimura T, Sugihara T, Sasaki T, Mitomi T, Shiina Y, Miwa T, Itakura M, Matsuzaki M, Shigeta H, Omori T, Kumagaya Y. Endoscopic diagnosis and treatment of mucosal carcinoma of the esophagus. Endosc Dig. 1990;4:447–52. (in Japanese with English abstr). Makuuchi H, Machimura T, Sugihara T, Sasaki T, Mitomi T, Shiina Y, Miwa T, Itakura M, Matsuzaki M, Shigeta H, Omori T, Kumagaya Y. Endoscopic diagnosis and treatment of mucosal carcinoma of the esophagus. Endosc Dig. 1990;4:447–52. (in Japanese with English abstr).
38.
Zurück zum Zitat Momma K, Sakaki N, Yoshida M. Endoscopic mucosectomy for precise evaluation and treatment of esophageal intraepithelial cancer. Endosc Dig. 1990;4:501–6. (in Japanese with English abstr). Momma K, Sakaki N, Yoshida M. Endoscopic mucosectomy for precise evaluation and treatment of esophageal intraepithelial cancer. Endosc Dig. 1990;4:501–6. (in Japanese with English abstr).
39.
Zurück zum Zitat Inoue H, Endo M. Endoscopic esophageal mucosal resection using a transparent tube. Surg Endosc. 1990;4:198–201.PubMedCrossRef Inoue H, Endo M. Endoscopic esophageal mucosal resection using a transparent tube. Surg Endosc. 1990;4:198–201.PubMedCrossRef
40.
Zurück zum Zitat Kouzu T, Arima M, Yamada H, Hishikawa E, Koide Y, Isono K. Endoscopic treatment of esophageal cancer. Jpn J Cancer Chemother. 1992;19:1255–60. (in Japanese with English abstr). Kouzu T, Arima M, Yamada H, Hishikawa E, Koide Y, Isono K. Endoscopic treatment of esophageal cancer. Jpn J Cancer Chemother. 1992;19:1255–60. (in Japanese with English abstr).
41.
Zurück zum Zitat Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M, Miyata Y. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005;3:67–70.CrossRef Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M, Miyata Y. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005;3:67–70.CrossRef
42.
Zurück zum Zitat Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432–9.PubMedCrossRef Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432–9.PubMedCrossRef
43.
Zurück zum Zitat Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–21.PubMed Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–21.PubMed
44.
Zurück zum Zitat Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2–3NanyM0 squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425–33.PubMedCrossRef Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2–3NanyM0 squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425–33.PubMedCrossRef
45.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 14th edn. Tokyo: Kanehara; 2010. (in Japanese). Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 14th edn. Tokyo: Kanehara; 2010. (in Japanese).
46.
Zurück zum Zitat Japanese Gastric Cancer Association. Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach, October 2010 edition, 3rd edn. Tokyo: Kanehara; 2010. (in Japanese). Japanese Gastric Cancer Association. Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach, October 2010 edition, 3rd edn. Tokyo: Kanehara; 2010. (in Japanese).
Metadaten
Titel
History of the Japanese Classification of Esophageal Cancer
verfasst von
Hiromasa Fujita
Publikationsdatum
01.12.2011
Verlag
Springer Japan
Erschienen in
Esophagus / Ausgabe 4/2011
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-011-0292-6

Weitere Artikel der Ausgabe 4/2011

Esophagus 4/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.